Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 15 July 2008, doi:10.1136/bmj.a788
Cite this as: BMJ 2008;337:a788
| The first 150 words of the full text of this article appear below. |
Buckwell pleads for an idealised state of transparent relations between the industry and key opinion leaders.1 The reality is different. Here is a description from an internationally recognised clinical scientist about his experience with the industry. I respect his confidentiality and that of the corporation. My colleagues experience is not atypical.
"When [the company] first began trumpeting the success of [their drug], I was asked to be on their speakers bureau. In a large audience ... I departed from the script I was given for the published data to note that the effect size ... was significantly lower than the [alternative treatments]. Since most [of the audience] had no idea what "effect size" is, I gave a brief explanation. That evening I received a phone call in my hotel room from [the companys] director of the program. He chastised me for being off message and warned me not to make
Bernard J Carroll, consultant
1 Pacific Behavioral Research Foundation, PO Box 223040, Carmel, CA 93922-3040, USA
bcarroll@redshift.com